AKT1 and Familial prostate cancer: Among the 137 KEGG pathways, the most significantly enriched included pathways related to cancer, EGFR tyrosine kinase inhibitor resistance, the PI3K–Akt signaling pathway, prostate cancer, proteoglycans in cancer, and endocrine resistance.